WALVAX BIOTECHNOLOGY CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.38 CNY | -2.84% |
|
-4.71% | -38.83% |
| Apr. 26 | Walvax Biotechnology's Profit Drops 92%, Operating Income Slids 28% in Q1 2024 | MT |
| Apr. 25 | Walvax Biotechnology's Unit to End COVID-19 Vaccine Trial | MT |
Quotes 5-day view
End-of-day quote Shenzhen S.E.| 2024-05-09 | 2024-05-10 | 2024-05-13 | 2024-05-14 | Today | 2024-05-14 | |
|---|---|---|---|---|---|---|
| Last | 15.41 ¥ | 15.07 ¥ | 14.77 ¥ | 14.8 ¥ | 14.38 ¥ | 14.38 ¥ |
| Volume | 24 998 900 | 17 372 300 | 15 994 940 | 11 511 870 | 13 508 720 | 13 508 720 |
| Change | +1.92% | -2.21% | -1.99% | +0.20% | -2.84% | -2.84% |
| Opening | 15.15 | 15.54 | 15.12 | 14.72 | 14.73 | 14.73 |
| High | 15.59 | 15.54 | 15.25 | 15.04 | 14.80 | 14.8 |
| Low | 14.98 | 15.00 | 14.75 | 14.71 | 14.37 | 14.37 |
Performance
| 1 day | -2.84% | ||
| 1 week | -4.71% | ||
| Current month | -2.24% | ||
| 1 month | -0.35% | ||
| 3 months | -18.34% | ||
| 6 months | -40.28% | ||
| Current year | -38.83% | ||
| 1 year | -51.76% | ||
| 3 years | -78.91% | ||
| 5 years | -38.55% | ||
| 10 years | +152.06% |
Volumes
marketsDaily volume
13 508 720
Avg. Volume 20 sessions
18 157 285
Avg. Volume 20 sessions CNY
261 101 758.30
Avg. Volume 20 sessions USD
36 168 598.86
Record volume 1
268 063 200
Record volume 2
239 207 300
Record volume 3
162 313 000
Capital turnover ratio
0.01
Float rotation
0.04
Basic data
Capitalization (CNY)
23 626 234 113
Capitalization (USD)
3 272 776 828
Net sales (CNY)
4 113 772 330
Net sales (USD)
569 852 084
Number of employees
2 388
Sales / Employee (CNY)
1 722 685
Sales / Employee (USD)
238 632
Free-Float
27.42 %
Free-Float capitalization (CNY)
6 542 617 276
Free-Float capitalization (USD)
906 302 973
Average Daily Capital Traded
1.11%
Highs and lows
1 week
14.37
15.59
1 month
13.1315.59
Current year
13.1323.66
1 year
13.1331.00
3 years
13.1396.73
5 years
13.1396.73
10 years
5.0596.73
Indicators
Moving average 5 days
14.89
Moving average 20 days
14.52
Moving average 50 days
15.92
Moving average 100 days
18.05
Price spread / (MMA5)
+3.55%
Price spread / (MMA20)
+0.97%
Price spread / (MMA50)
+10.71%
Price spread / (MMA100)
+25.52%
STIM
RSI 9 days
39.75
RSI 14 days
40.79
Sector Comparison - Biopharmaceuticals
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -2.84% | -4.71% | -38.83% | -51.76% | 3.27B | ||
| +1.24% | +1.25% | -1.26% | -7.61% | 89.46B | ||
| 0.00% | -0.51% | +2.76% | 0.00% | 40.74B | ||
| +4.02% | +7.39% | -8.81% | -24.34% | 33.03B | ||
| +1.91% | +1.07% | +55.32% | +41.87% | 24.68B | ||
| +1.22% | -1.40% | -16.32% | -15.23% | 15.12B | ||
| +0.29% | +6.92% | -8.88% | -13.57% | 12.81B | ||
| -1.83% | -5.98% | -12.11% | -5.92% | 11.79B | ||
| -2.02% | -6.56% | -43.61% | -29.78% | 11.64B | ||
| +1.55% | +1.48% | +7.79% | +21.13% | 8.9B | ||
| -0.13% | -1.13% | -7.72% | -0.75% | 8.22B | ||
| +2.35% | +0.34% | -6.13% | +3.57% | 6.94B | ||
| -1.77% | -0.07% | -3.39% | +16.03% | 6.93B | ||
| -1.07% | +1.09% | -7.12% | +14.66% | 6.86B | ||
| +6.14% | -1.58% | +77.16% | +295.69% | 6.78B | ||
| +3.37% | +9.16% | -34.13% | -10.23% | 6.33B | ||
| Average | +0.73% | -0.94% | -2.83% | +14.61% | ||
| Weighted average by Cap. | +1.11% | -0.21% | +0.46% | +3.12% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | -38.83% | ||
| 2023 | -41.50% | ||
| 2022 | -28.49% | ||
| 2021 | +45.75% | ||
| 2020 | +18.87% | ||
| 2019 | +69.84% | ||
| 2018 | +4.66% | ||
| 2017 | +67.43% | ||
| 2016 | -17.30% | ||
| 2015 | +95.89% | ||
| 2014 | +34.60% | ||
| 2013 | +4.39% | ||
| 2012 | -1.73% | ||
| 2011 | -48.64% | ||
| 2010 | -2.31% |
- Stock Market
- Equities
- 300142 Stock
- Quotes Walvax Biotechnology Co., Ltd.
